Search Results - Manuel Neuberger
- Showing 1 - 5 results of 5
-
1
Loss of YTHDC1 m6A reading function promotes invasiveness in urothelial carcinoma of the bladder by Jinyun Xu, Jonas Koch, Claudia Schmidt, Malin Nientiedt, Manuel Neuberger, Philipp Erben, Maurice Stephan Michel, Manuel Rodríguez-Paredes, Frank Lyko
Published in Experimental and Molecular Medicine (2025-01-01)Get full text
Article -
2
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq by Frank Waldbillig, Felix Bormann, Manuel Neuberger, Jörg Ellinger, Philipp Erben, Maximilian C. Kriegmair, Maurice Stephan Michel, Philipp Nuhn, Malin Nientiedt
Published in Diagnostics (2023-02-01)Get full text
Article -
3
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocol by Maximilian Christian Kriegmair, Karl-Friedrich Kowalewski, Marie Angela Sidoti Abate, Manuel Neuberger, Marietta Kirchner, Regina Krisam, Luisa Egen, Caelan Max Haney, Fabian Siegel, Maurice-Stephan Michel, Patrick Honeck, Philipp Nuhn, Niklas Westhoff
Published in BMJ Open (2021-11-01)Get full text
Article -
4
Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder by Jonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, Jinyun Xu, Vitor Coutinho Carneiro, Jörg Ellinger, Maximilian C. Kriegmair, Philipp Nuhn, Philipp Erben, Maurice Stephan Michel, Mark Helm, Manuel Rodríguez-Paredes, Malin Nientiedt, Frank Lyko
Published in iScience (2023-08-01)Get full text
Article -
5
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy by Manuel Neuberger, Christel Weiß, Nora Goly, Janina Skladny, Katja Nitschke, Frederik Wessels, Karl F. Kowalewski, Frank Waldbillig, Friedrich Hartung, Malin Nientiedt, Luisa Egen, Jonas Herrmann, Jonas Jarczyk, Margarete Teresa Walach, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn
Published in Discover Oncology (2022-12-01)Get full text
Article
